Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Pahlman LA, Hohenberger W, Matzel K, Sugihara K, Quirke P, Glimelius B (2016)

Publication Type: Journal article

Publication year: 2016

Journal

Journal of Clinical Oncology American Society of Clinical Oncology

Book Volume: 34

Pages Range: 1297-9

Journal Issue: 12

DOI: 10.1200/JCO.2015.65.3048

Authors with CRIS profile

Werner Hohenberger Lehrstuhl für Allgemein- und Viszeralchirurgie Klaus Matzel Lehrstuhl für Allgemein- und Viszeralchirurgie

Involved external institutions

Uppsala University SE Sweden (SE) Tokyo Medical and Dental University (TMDU) / 東京医科歯科大学 JP Japan (JP) St James's University Hospital GB United Kingdom (GB)

How to cite

APA:

Pahlman, L.A., Hohenberger, W., Matzel, K., Sugihara, K., Quirke, P., & Glimelius, B. (2016). Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated? Journal of Clinical Oncology, 34(12), 1297-9. https://doi.org/10.1200/JCO.2015.65.3048

MLA:

Pahlman, Lars A., et al. "Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?" Journal of Clinical Oncology 34.12 (2016): 1297-9.

BibTeX: Download